Ivivi Technologies to Present at Noble Financial Two Double-0-Seven Conference, August 20, 2007

  
    
  
  
    
      Ivivi Technologies, Inc. (AMEX:II), today announced that André 
      DiMino, Vice Chairman and Co-CEO, and David Saloff, President and 
      Co-CEO, are scheduled to present a corporate overview at the Noble 
      Financial Equity Conference on August 20, 2007 at the Charleston Place 
      Hotel in Charleston, South Carolina. Management will also participate in 
      a question and answer session following the presentation and one-on-one 
      meetings throughout the day.
    
    
      Ivivi Technologies’ presentation is scheduled 
      for 10:00 am Eastern Time. Individuals interested in listening to the 
      live presentation can participate by going to the Investor Relations 
      section of the Company’s website www.ivivitechnologies.com 
      under Events and Presentations or by going to Noble Financial’s 
      conference website at www.two-007.net. 
      It is recommended that interested parties register at least 15 minutes 
      prior to the start of the presentation to ensure timely access. A replay 
      of the webcast will also be available for 90 days.
    
    
      About Ivivi Technologies, Inc.
    
    
      Based in Northvale, NJ, Ivivi Technologies, Inc. is a medical technology 
      company focusing on designing, developing and commercializing its 
      proprietary electrotherapeutic technology platform. Ivivi’s 
      research and development activities are focused specifically on pulsed 
      electromagnetic field, or PEMF, technology, which, by creating a 
      therapeutic electrical current in injured soft tissue, stimulates 
      biochemical and physiological healing processes to help repair the 
      injured tissue and reduce related pain and inflammation. The Company’s 
      Electroceuticals™ have been used in 
      non-invasive treatments for a wide array of conditions, including 
      chronic wounds, pain and edema following plastic and reconstructive 
      surgery and chronic inflammatory disorders.
    
    
      About Noble Financial
    
    
      Noble Financial is a privately-held, full-service capital markets firm 
      driven by what is often overlooked by other firms - uncovering the value 
      embedded in the orphaned, undiscovered or misunderstood company. The 
      company focuses on converting market inefficiencies into profit 
      opportunities. Noble Financial supports emerging companies through 
      strategic advice, investment banking, market-making, sales & trading, 
      comprehensive equity research, and the development of institutional 
      support. Noble Financial’s equity conferences – 
      2007 marks their third annual - allow for a unique blend of professional 
      and personal interaction among a diverse cross-section of executives. 
      The company has operated for 23 years and has offices in Florida and New 
      York City.
    
    Conference Information: www.two-007.net or [e-mail]
Investor Registration: www.two-007.net/RegistrationInvestorBuyside.htm
Noble Financial Website: www.nobleresearch.com
    
      Forward-Looking Statements
    
    
      This release contains "forward-looking statements" made pursuant to the 
      safe harbor provisions of the Private Securities Litigation Reform Act 
      of 1995 including those related to our cardiac study at the Cleveland 
      Clinic, strategic partnerships and future sales. Forward-looking 
      statements reflect management's current knowledge, assumptions, judgment 
      and expectations regarding future performance or events. Although 
      management believes that the expectations reflected in such statements 
      are reasonable, they give no assurance that such expectations will prove 
      to be correct and you should be aware that actual results could differ 
      materially from those contained in the forward-looking statements. 
      Forward-looking statements are subject to a number of risks and 
      uncertainties, including, but not limited to, the Company’s 
      limited operating history, history of significant and continued 
      operating losses and substantial accumulated earnings deficit, 
      difficulties with its financial accounting controls, the failure of the 
      market for the Company’s products to continue 
      to develop, the inability for customers to receive third party 
      reimbursement, the inability to obtain additional capital, the inability 
      to protect the Company’s intellectual 
      property, the loss of any executive officers or key personnel or 
      consultants, competition, changes in the regulatory landscape or the 
      imposition of regulations that affect the Company’s 
      products and other risks detailed from time to time in the Company’s 
      filings with the Securities and Exchange Commission, including the 
      Company’s Form 10-KSB for the fiscal year 
      ended March 31, 2007. The Company assumes no obligation to update the 
      information contained in this press release.